PLAY PODCASTS
Zoë chats with Dr Ben Bikman about the use and effects of GLP-1 Agonists (Semaglutide - Ozempic and Wegovy)

Zoë chats with Dr Ben Bikman about the use and effects of GLP-1 Agonists (Semaglutide - Ozempic and Wegovy)

Diet and Health Today · Zoë Harcombe

September 5, 20241h 9m

Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode, Zoë chats with Dr Benjamin Bikman about GLP-1 agonists, a class of drugs used for weight loss and diabetes management. They discuss the role of GLP-1 in metabolism, the effects of GLP-1 agonists on weight loss and insulin sensitivity, and the potential side effects and limitations of these drugs.

Dr Bikman explains how GLP-1 agonists slow down intestinal movement, leading to feelings of nausea and reduced appetite. He also discusses the paradox of these drugs stimulating the growth of new fat cells while promoting weight loss.

Enjoy the video, transcript and show notes over at https://zoeharcombe.com

Full show notes and video over at https://www.zoeharcombe.com